-
A new report by AARP found that the top 25 drugs — covered under Medicare Part D — have almost tripled in price since they first entered the market.
-
Insurers selling coverage in North Carolina, Pennsylvania and New York, among other states, say they won’t cover Leqembi with insurance offered on the individual market and through employers because they see the $26,000-a-year drug as experimental.
-
Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.
-
The multiyear agreement was reached just before the deadline. According to UnitedHealthcare, negotiations stalled due to a disagreement over Medicare Advantage and Medicaid contracts.
-
Medicare soon will start something it hasn't done in its 58-year history: negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.
-
Medicare was supposed to cover the entire cost of his procedure. But the anesthesia provider failed to file its claims in a timely manner and billed the patient instead.
-
The first lady says cancer patients need help making decisions about their treatment and that help from a navigator will make a big difference in people's lives.
-
The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.
-
In one case filed in the Southern District of Florida, investigators said they found nearly $2 billion in fraudulent telemedicine claims submitted to government-funded coverage programs like Medicare and Medicaid.
-
Veterans rated VA hospitals higher than private facilities for things like patient satisfaction, hospital cleanliness and communication with nurses and doctors.